INTERACTION, Monitoring of Stroke Patients in Hospital and Home Environment

Stroke Clinical Trial

— INTERACTION  

Official title:

Proof of Concept Study of the INTERACTION Technology, Monitoring of Stroke Patients in Hospital and Home Environment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02118363
• Other study ID #: 13101
• Secondary ID: seventh framewor
• Status: Completed
• Start date: April 2014
• Est. completion date: December 2017

Study information

• Verified date: May 2018
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Clinical assessment and monitoring of balance and arm function in stroke patients with sensor based measurement, in clinical and home environment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Age: 18 or above

• Previous Stroke in the personal history

• Able to walk 10 meters. A walking aid (unilateral or bilateral) is permitted

• Able to walk without special shoes

• Able to raise the arm against gravity

• Able to read and understand questionnaires and able to execute commands

• Able and willing to participate in the study

• Singed Informed Consent

Exclusion Criteria:

• Contraindications on ethical grounds (vulnerable persons)

• known or suspected non-compliance, drug or alcohol abuse,

• Severe aphasia

• Severe dementia

• Severe depression

• Relevant medical disease or increased risk of rehospitalization

• Severe sensory deficits

• Severe neglect

Related Conditions & MeSH terms

• Stroke

Locations

Country	Name	City	State
Switzerland	Cereneo	Vitznau

Sponsors (6)

Lead Sponsor	Collaborator
University of Zurich	Roessingh, Smartex S.r.l., University of Pisa, University of Twente, XSens technologies B.V.

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	proof of concept		3 month

External Links

•   Link